BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33909099)

  • 21. Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China.
    Song Z; Ma H; Sun H; Li Q; Liu Y; Xie J; Feng Y; Shang Y; Ma K; Zhang N; Wang J
    BMC Cancer; 2023 Dec; 23(1):1182. PubMed ID: 38041067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis.
    Cai Z; Gu X; Xie J; Cheng D; Chen J; Cheng J; Ye J; Lv T
    Transl Lung Cancer Res; 2023 Oct; 12(10):1987-2000. PubMed ID: 38025813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer.
    Li B; Jiang C; Wang R; Zou B; Xie P; Li W; Sun X; Yu J; Wang L
    Onco Targets Ther; 2020; 13():9043-9057. PubMed ID: 32982294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
    Zhao J; He Y; Yang X; Tian P; Zeng L; Huang K; Zhao J; Zhou J; Zhu Y; Wang Q; Chen M; Li W; Gao Y; Zhang Y; Xia Y
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomogram to predict cause-specific mortality in extensive-stage small cell lung cancer: A competing risk analysis.
    Zhong J; Zheng Q; An T; Zhao J; Wu M; Wang Y; Zhuo M; Li J; Zhao X; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
    Thorac Cancer; 2019 Sep; 10(9):1788-1797. PubMed ID: 31318178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis.
    Hoffmann E; De-Colle C; Potkrajcic V; Baumann D; Spengler W; Gani C; Utz D
    Strahlenther Onkol; 2023 Jul; 199(7):668-675. PubMed ID: 37039832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study.
    Zheng Z; Yuan X; Zhou Y; Chu L; Yang X; Ni J; Chu Q; Chu X; Liu Y; Zhu Z
    Ann Transl Med; 2023 Jan; 11(2):60. PubMed ID: 36819545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
    Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
    Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
    Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
    Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
    J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1.
    Liu C; Jin B; Liu Y; Juhua O; Bao B; Yang B; Liu X; Yu P; Luo Y; Wang S; Teng Z; Song N; Qu J; Zhao J; Chen Y; Qu X; Zhang L
    Cancer Med; 2023 Apr; 12(8):9527-9540. PubMed ID: 37015898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy.
    Yuan X; Zheng Z; Liu F; Gao Y; Zhang W; Berardi R; Mohindra P; Zhu Z; Lin J; Chu Q
    Transl Lung Cancer Res; 2021 May; 10(5):2163-2171. PubMed ID: 34164267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superior vena cava syndrome revisited.
    Chen YM; Yang S; Perng RP; Tsai CM
    Jpn J Clin Oncol; 1995 Apr; 25(2):32-6. PubMed ID: 7745820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer.
    Xie Z; Liu J; Wu M; Wang X; Lu Y; Han C; Cong L; Li J; Meng X
    J Clin Med; 2023 Jun; 12(11):. PubMed ID: 37298023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer.
    Li-Ming X; Zhao LJ; Simone CB; Cheng C; Kang M; Wang X; Gong LL; Pang QS; Wang J; Yuan ZY; Wang P
    Radiother Oncol; 2017 Nov; 125(2):331-337. PubMed ID: 29079309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.
    Xu LM; Cheng C; Kang M; Luo J; Gong LL; Pang QS; Wang J; Yuan ZY; Zhao LJ; Wang P
    Sci Rep; 2017 Aug; 7(1):9255. PubMed ID: 28835666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective stenting study on superior vena cava syndrome caused by lung cancer.
    Wei S; Liu J; Li X; Song Z; Dong M; Zhao H; Zhao Q; Chen G; Chen J
    Thorac Cancer; 2020 Jul; 11(7):1835-1839. PubMed ID: 32438532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma.
    Duijm M; Oomen-de Hoop E; van Voort van der Zyp N; van de Vaart P; Tekatli H; Hoogeman M; Senan S; Nuyttens J
    Radiother Oncol; 2021 Mar; 156():223-230. PubMed ID: 33418006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
    Patrice GI; Lester-Coll NH; Yu JB; Amdahl J; Delea TE; Patrice SJ
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):97-106. PubMed ID: 29029885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.